Logo image of HGBL

HERITAGE GLOBAL INC (HGBL) Stock Fundamental Analysis

NASDAQ:HGBL - US42727E1038 - Common Stock

1.91 USD
-0.02 (-1.04%)
Last: 8/29/2025, 8:00:01 PM
Fundamental Rating

4

Overall HGBL gets a fundamental rating of 4 out of 10. We evaluated HGBL against 239 industry peers in the Capital Markets industry. Both the profitability and the financial health of HGBL get a neutral evaluation. Nothing too spectacular is happening here. HGBL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HGBL was profitable.
HGBL had a positive operating cash flow in the past year.
HGBL had positive earnings in each of the past 5 years.
HGBL had a positive operating cash flow in 4 of the past 5 years.
HGBL Yearly Net Income VS EBIT VS OCF VS FCFHGBL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

1.2 Ratios

HGBL has a Return On Assets of 4.09%. This is in the better half of the industry: HGBL outperforms 61.09% of its industry peers.
Looking at the Return On Equity, with a value of 5.46%, HGBL is doing worse than 60.25% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.44%, HGBL is doing good in the industry, outperforming 73.64% of the companies in the same industry.
HGBL had an Average Return On Invested Capital over the past 3 years of 9.06%. This is in line with the industry average of 7.59%.
Industry RankSector Rank
ROA 4.09%
ROE 5.46%
ROIC 6.44%
ROA(3y)14.77%
ROA(5y)14.4%
ROE(3y)20.15%
ROE(5y)20.41%
ROIC(3y)9.06%
ROIC(5y)7.53%
HGBL Yearly ROA, ROE, ROICHGBL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Profit Margin, with a value of 7.33%, HGBL is doing worse than 62.76% of the companies in the same industry.
In the last couple of years the Profit Margin of HGBL has declined.
With a Operating Margin value of 12.89%, HGBL is not doing good in the industry: 66.95% of the companies in the same industry are doing better.
HGBL's Operating Margin has improved in the last couple of years.
The Gross Margin of HGBL (63.52%) is better than 72.38% of its industry peers.
HGBL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.89%
PM (TTM) 7.33%
GM 63.52%
OM growth 3Y13.35%
OM growth 5Y10.34%
PM growth 3Y-1.15%
PM growth 5Y-5.18%
GM growth 3Y-1.1%
GM growth 5Y-0.45%
HGBL Yearly Profit, Operating, Gross MarginsHGBL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

The number of shares outstanding for HGBL has been reduced compared to 1 year ago.
HGBL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HGBL has an improved debt to assets ratio.
HGBL Yearly Shares OutstandingHGBL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HGBL Yearly Total Debt VS Total AssetsHGBL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

HGBL has an Altman-Z score of -0.76. This is a bad value and indicates that HGBL is not financially healthy and even has some risk of bankruptcy.
HGBL has a worse Altman-Z score (-0.76) than 80.75% of its industry peers.
HGBL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
HGBL has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. HGBL outperforms 82.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -0.76
ROIC/WACCN/A
WACCN/A
HGBL Yearly LT Debt VS Equity VS FCFHGBL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

HGBL has a Current Ratio of 2.05. This indicates that HGBL is financially healthy and has no problem in meeting its short term obligations.
HGBL has a Current ratio of 2.05. This is in the better half of the industry: HGBL outperforms 71.97% of its industry peers.
A Quick Ratio of 1.69 indicates that HGBL should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.69, HGBL is doing good in the industry, outperforming 68.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.69
HGBL Yearly Current Assets VS Current LiabilitesHGBL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

The earnings per share for HGBL have decreased strongly by -66.67% in the last year.
HGBL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.44% yearly.
Looking at the last year, HGBL shows a very negative growth in Revenue. The Revenue has decreased by -11.05% in the last year.
HGBL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.63% yearly.
EPS 1Y (TTM)-66.67%
EPS 3Y15.87%
EPS 5Y1.44%
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-11.05%
Revenue growth 3Y20.71%
Revenue growth 5Y11.63%
Sales Q2Q%18.97%

3.2 Future

The Earnings Per Share is expected to grow by 22.71% on average over the next years. This is a very strong growth
HGBL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.54% yearly.
EPS Next Y14.15%
EPS Next 2Y22.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.26%
Revenue Next 2Y9.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HGBL Yearly Revenue VS EstimatesHGBL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
HGBL Yearly EPS VS EstimatesHGBL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.10, HGBL is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as HGBL.
HGBL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.13.
With a Price/Forward Earnings ratio of 9.06, the valuation of HGBL can be described as very reasonable.
Based on the Price/Forward Earnings ratio, HGBL is valued cheaply inside the industry as 81.17% of the companies are valued more expensively.
HGBL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 19.1
Fwd PE 9.06
HGBL Price Earnings VS Forward Price EarningsHGBL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

92.47% of the companies in the same industry are more expensive than HGBL, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.41
HGBL Per share dataHGBL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

HGBL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HGBL's earnings are expected to grow with 22.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.35
PEG (5Y)13.31
EPS Next 2Y22.71%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

HGBL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HERITAGE GLOBAL INC

NASDAQ:HGBL (8/29/2025, 8:00:01 PM)

1.91

-0.02 (-1.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners38.4%
Inst Owner Change-6.4%
Ins Owners12.88%
Ins Owner Change1.08%
Market Cap66.35M
Analysts84
Price Target3.75 (96.34%)
Short Float %0.25%
Short Ratio1.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.11%
Min EPS beat(2)-21.57%
Max EPS beat(2)15.34%
EPS beat(4)1
Avg EPS beat(4)-44.55%
Min EPS beat(4)-121.01%
Max EPS beat(4)15.34%
EPS beat(8)2
Avg EPS beat(8)-17.7%
EPS beat(12)6
Avg EPS beat(12)6.86%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)2
Avg Revenue beat(2)12.2%
Min Revenue beat(2)10.82%
Max Revenue beat(2)13.58%
Revenue beat(4)2
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-23.68%
Max Revenue beat(4)13.58%
Revenue beat(8)3
Avg Revenue beat(8)-4.32%
Revenue beat(12)6
Avg Revenue beat(12)3.57%
Revenue beat(16)9
Avg Revenue beat(16)3.89%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)-29.42%
EPS NY rev (1m)1.08%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)7.69%
Revenue NQ rev (3m)-8.91%
Revenue NY rev (1m)7.9%
Revenue NY rev (3m)8.77%
Valuation
Industry RankSector Rank
PE 19.1
Fwd PE 9.06
P/S 1.36
P/FCF N/A
P/OCF 14.71
P/B 1.01
P/tB 1.21
EV/EBITDA 7.41
EPS(TTM)0.1
EY5.24%
EPS(NY)0.21
Fwd EY11.04%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.13
OCFY6.8%
SpS1.41
BVpS1.89
TBVpS1.58
PEG (NY)1.35
PEG (5Y)13.31
Profitability
Industry RankSector Rank
ROA 4.09%
ROE 5.46%
ROCE 8.76%
ROIC 6.44%
ROICexc 8.88%
ROICexgc 11.17%
OM 12.89%
PM (TTM) 7.33%
GM 63.52%
FCFM N/A
ROA(3y)14.77%
ROA(5y)14.4%
ROE(3y)20.15%
ROE(5y)20.41%
ROIC(3y)9.06%
ROIC(5y)7.53%
ROICexc(3y)11.88%
ROICexc(5y)13.37%
ROICexgc(3y)15.54%
ROICexgc(5y)N/A
ROCE(3y)12.33%
ROCE(5y)10.25%
ROICexcg growth 3Y-7.36%
ROICexcg growth 5Y-37.82%
ROICexc growth 3Y8.82%
ROICexc growth 5Y-8.63%
OM growth 3Y13.35%
OM growth 5Y10.34%
PM growth 3Y-1.15%
PM growth 5Y-5.18%
GM growth 3Y-1.1%
GM growth 5Y-0.45%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 0.6
Cap/Depr 1410.95%
Cap/Sales 15.54%
Interest Coverage -70.11
Cash Conversion 65.86%
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.69
Altman-Z -0.76
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)37.97%
Cap/Depr(5y)85.51%
Cap/Sales(3y)0.4%
Cap/Sales(5y)1.36%
Profit Quality(3y)96.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3Y15.87%
EPS 5Y1.44%
EPS Q2Q%-28.57%
EPS Next Y14.15%
EPS Next 2Y22.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.05%
Revenue growth 3Y20.71%
Revenue growth 5Y11.63%
Sales Q2Q%18.97%
Revenue Next Year15.26%
Revenue Next 2Y9.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-40.08%
EBIT growth 3Y36.82%
EBIT growth 5Y23.17%
EBIT Next Year-6.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-126.63%
FCF growth 3YN/A
FCF growth 5Y62.57%
OCF growth 1Y-62.47%
OCF growth 3YN/A
OCF growth 5Y57.86%